NFE2L2 and myeloid leukemia: Their influence on ROS metabolism was demonstrated by using K562 myelogenous leukemia cells engineered to report NRF2 activation and compared with peripheral blood mononuclear cells (PBMCs) with a special focus on T lymphocytes.